Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020

Author:

Boyd Andrew T.ORCID,Jahun Ibrahim,Dirlikov Emilio,Greby Stacie,Odafe Solomon,Abdulkadir Alhassan,Odeyemi Olugbenga,Dalhatu Ibrahim,Ogbanufe Obinna,Abutu Andrew,Asaolu Olugbenga,Bamidele Moyosola,Onyenuobi Chibuzor,Efuntoye Timothy,Fagbamigbe Johnson O.,Ene Uzoma,Fagbemi Ayodele,Tingir Nguhemen,Meribe Chidozie,Ayo Adeola,Bassey Orji,Nnadozie Obinna,Boyd Mary Adetinuke,Onotu Dennis,Gwamna Jerry,Okoye McPaul,Abrams William,Alagi Matthias,Oladipo Ademola,Williams-Sherlock Michelle,Bachanas Pamela,Chun Helen,Carpenter Deborah,Miller David A.,Ijeoma Ugonna,Nwaohiri Anuli,Dakum Patrick,Mensah Charles O.,Aliyu Ahmad,Oyeledun Bolanle,Okonkwo Prosper,Oko John O.,Ikpeazu Akudo,Aliyu Gambo,Ellerbrock Tedd,Swaminathan Mahesh

Abstract

Abstract Background To accelerate progress toward the UNAIDS 90-90-90 targets, US Centers for Disease Control and Prevention Nigeria country office (CDC Nigeria) initiated an Antiretroviral Treatment (ART) Surge in 2019 to identify and link 340,000 people living with HIV/AIDS (PLHIV) to ART. Coronavirus disease 2019 (COVID-19) threatened to interrupt ART Surge progress following the detection of the first case in Nigeria in February 2020. To overcome this disruption, CDC Nigeria designed and implemented adapted ART Surge strategies during February–September 2020. Methods Adapted ART Surge strategies focused on continuing expansion of HIV services while mitigating COVID-19 transmission. Key strategies included an intensified focus on community-based, rather than facility-based, HIV case-finding; immediate initiation of newly-diagnosed PLHIV on 3-month ART starter packs (first ART dispense of 3 months of ART); expansion of ART distribution through community refill sites; and broadened access to multi-month dispensing (MMD) (3–6 months ART) among PLHIV established in care. State-level weekly data reporting through an Excel-based dashboard and individual PLHIV-level data from the Nigeria National Data Repository facilitated program monitoring. Results During February–September 2020, the reported number of PLHIV initiating ART per month increased from 11,407 to 25,560, with the proportion found in the community increasing from 59 to 75%. The percentage of newly-identified PLHIV initiating ART with a 3-month ART starter pack increased from 60 to 98%. The percentage of on-time ART refill pick-ups increased from 89 to 100%. The percentage of PLHIV established in care receiving at least 3-month MMD increased from 77 to 93%. Among PLHIV initiating ART, 6-month retention increased from 74 to 92%. Conclusions A rapid and flexible HIV program response, focused on reducing facility-based interactions while ensuring delivery of lifesaving ART, was critical in overcoming COVID-19-related service disruptions to expand access to HIV services in Nigeria during the first eight months of the pandemic. High retention on ART among PLHIV initiating treatment indicates immediate MMD in this population may be a sustainable practice. HIV program infrastructure can be leveraged and adapted to respond to the COVID-19 pandemic.

Funder

u.s. president’s emergency plan for aids relief

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Reference24 articles.

1. UNAIDS Country factsheets: Nigeria 2019 2020. https://www.unaids.org/en/regionscountries/countries/nigeria.

2. Nigeria FMoH. Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018: Technical Report. Abuja, Nigeria; 2019.

3. UNAIDS. 90-90-90: An ambitious treatment target to end the AIDS epidemic. Geneva; 2014.

4. Dirlikov E, Jahun I, Odafe SF, Obinna O, Onyenuobi C, Ifunanya M, et al. Rapid scale-up of an antiretroviral therapy program before and during the COVID-19 pandemic—Nine States, Nigeria, March 31, 2019-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(12):421–6.

5. Nigeria Centre for Disease Control. 100 days of Nigeria COVID-19 response Abuja, Nigeria: Nigeria Centre for Disease Control; 2020 [updated June 08, 2020; cited 2021 March 15,]. https://ncdc.gov.ng/news/253/100-days-of-nigeria-covid-19-response.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3